ffeng	10.1200/JCO.2018.36.6_suppl.TPS154	<http://dx.doi.org/10.1200/jco.2018.36.6_suppl.tps154>; rel="canonical"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1200/JCO.2018.36.6_suppl.TPS154"><j.0:publisher>American Society of Clinical Oncology (ASCO)</j.0:publisher><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2018-02-20</j.0:date><j.0:identifier>10.1200/jco.2018.36.6_suppl.tps154</j.0:identifier><j.2:doi>10.1200/jco.2018.36.6_suppl.tps154</j.2:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/felix-y-feng-57bmuxyu44ti"><j.3:name>Felix Y Feng</j.3:name><j.3:familyName>Feng</j.3:familyName><j.3:givenName>Felix Y</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/elai-davicioni-57bmuxyu44ti"><j.3:name>Elai Davicioni</j.3:name><j.3:familyName>Davicioni</j.3:familyName><j.3:givenName>Elai</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>36</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/rodney-dunn-57bmuxyu44ti"><j.3:name>Rodney Dunn</j.3:name><j.3:familyName>Dunn</j.3:familyName><j.3:givenName>Rodney</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/anna-johnson-57bmuxyu44ti"><j.3:name>Anna Johnson</j.3:name><j.3:familyName>Johnson</j.3:familyName><j.3:givenName>Anna</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/david-christopher-miller-57bmuxyu44ti"><j.3:name>David Christopher Miller</j.3:name><j.3:familyName>Miller</j.3:familyName><j.3:givenName>David Christopher</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/ghani-khurshid-57bmuxyu44ti"><j.3:name>Ghani Khurshid</j.3:name><j.3:familyName>Khurshid</j.3:familyName><j.3:givenName>Ghani</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/james-e-montie-57bmuxyu44ti"><j.3:name>James E. Montie</j.3:name><j.3:familyName>Montie</j.3:familyName><j.3:givenName>James E.</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="info:doi/10.1200/jco.2018.36.6_suppl.tps154"/><j.1:startingPage>TPS154</j.1:startingPage><j.2:pageEnd>TPS154</j.2:pageEnd><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/linda-okoth-57bmuxyu44ti"><j.3:name>Linda Okoth</j.3:name><j.3:familyName>Okoth</j.3:familyName><j.3:givenName>Linda</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="doi:10.1200/jco.2018.36.6_suppl.tps154"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/linsell-susan-57bmuxyu44ti"><j.3:name>Linsell Susan</j.3:name><j.3:familyName>Susan</j.3:familyName><j.3:givenName>Linsell</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>TPS154</j.2:pageStart><j.1:endingPage>TPS154</j.1:endingPage><owl:sameAs rdf:resource="http://dx.doi.org/10.1200/jco.2018.36.6_suppl.tps154"/><j.1:doi>10.1200/jco.2018.36.6_suppl.tps154</j.1:doi><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0732-183X"><j.1:issn>1527-7755</j.1:issn><j.2:issn>1527-7755</j.2:issn><owl:sameAs>urn:issn:1527-7755</owl:sameAs><owl:sameAs>urn:issn:0732-183X</owl:sameAs><j.0:title>Journal of Clinical Oncology</j.0:title><j.1:issn>0732-183X</j.1:issn><j.2:issn>0732-183X</j.2:issn></j.2:Journal></j.0:isPartOf><j.2:volume>36</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/marguerite-du-plessis-57bmuxyu44ti"><j.3:name>Marguerite Du Plessis</j.3:name><j.3:familyName>Du Plessis</j.3:familyName><j.3:givenName>Marguerite</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/todd-matthew-morgan-57bmuxyu44ti"><j.3:name>Todd Matthew Morgan</j.3:name><j.3:familyName>Morgan</j.3:familyName><j.3:givenName>Todd Matthew</j.3:givenName></j.3:Person></j.0:creator><j.0:title>Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR).</j.0:title><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/michael-l-cher-57bmuxyu44ti"><j.3:name>Michael L. Cher</j.3:name><j.3:familyName>Cher</j.3:familyName><j.3:givenName>Michael L.</j.3:givenName></j.3:Person></j.0:creator></rdf:Description></rdf:RDF>
